Interleukin-6 and C-Reactive protein in metastatic breast cancer patients treated with eribulin

Breast Cancer Res Treat. 2024 Feb;203(3):627. doi: 10.1007/s10549-023-07156-y. Epub 2023 Oct 25.

Author

Kadri Altundag¹

Affiliation

¹ MKA Breast Cancer Clinic, Tepe Prime, 06800, Ankara, Turkey. altundag66@yahoo.com.

PMID: 37878153
DOI: 10.1007/s10549-023-07156-y

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents* / therapeutic use
Breast Neoplasms* / drug therapy
Breast Neoplasms* / pathology
C-Reactive Protein / therapeutic use
Female
Furans / adverse effects
Humans
Interleukin-6
Ketones / adverse effects
Polyether Polyketides*

Substances

eribulin
C-Reactive Protein
Interleukin-6
Antineoplastic Agents
Furans
Ketones
Polyether Polyketides